The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Impact BioMedical Inc (AMEX: IBO) was $0.52 for the day, up 5.31% from the previous closing price of $0.49. In other words, the price has increased by $5.31 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
Our analysis of IBO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.17 and its Current Ratio is at 0.22. In the meantime, Its Debt-to-Equity ratio is 2.38 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 22 ’25 when DSS, INC. sold 115,600 shares for $0.55 per share. The transaction valued at 63,476 led to the insider holds 45,400 shares of the business.
DSS, INC. sold 45,400 shares of IBO for $24,530 on May 27 ’25. The 10% Owner now owns 0 shares after completing the transaction at $0.54 per share. On Apr 04 ’25, another insider, DSS, INC., who serves as the 10% Owner of the company, sold 890,800 shares for $0.95 each. As a result, the insider received 845,013 and left with 161,100 shares of the company.
Stock Price History:
Over the past 52 weeks, IBO has reached a high of $6.17, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is -40.46%, while the 200-Day Moving Average is calculated to be -67.96%.
Shares Statistics:
A total of 12.09M shares are outstanding, with a floating share count of 11.98M. Insiders hold about 0.85% of the company’s shares, while institutions hold 3.19% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
